Home > Neurology > AAN 2022 > Migraine > Telemedicine during COVID-19 pandemic highly appreciated

Telemedicine during COVID-19 pandemic highly appreciated

Presented By
Dr Chia-Chun Chiang, Mayo Clinic, MN, USA
Presented by
Chia-Chun Chiang Mayo Clinic
Conference
AAN 2022
Doi
https://doi.org/10.55788/d4871235
On behalf of the American Migraine Foundation (AMF), the patient experience of telemedicine for headache care during the COVID-19 pandemic was evaluated. Telemedicine resulted in high patient satisfaction rates. Almost all participants indicated that they would prefer to continue to use telemedicine for their headache care. Dr Chia-Chun Chiang (Mayo Clinic, MN, USA) presented the results of one of the first studies to assess the patient perspective of telemedicine for headache care [1]. The AMF designed a standardised electronic questionnaire with 15 questions that was sent to over 100,000 AMF members to evaluate the period between March and September 2020. The results were published in Headache in May 2021 [2]. Included were 1,172 respondents. The average age was 49.5 years; 1,017 (88%) were women. Of 1,127 respondents, 648 (57.5%) said they had used telemedicine visits for headache care during the study period. Among this group,...


Please login to read the full text of the article.


If you have no account yet, please register now.





Posted on